Viewing Study NCT01142661


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2026-01-28 @ 8:32 AM
Study NCT ID: NCT01142661
Status: COMPLETED
Last Update Posted: 2013-09-20
First Post: 2010-06-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed Therapies
Sponsor:
Organization: